Gene · 862
Papers4,591
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 4,591
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The emerging role of snoRNAs in human disease. | Genes Dis | 2023 | 37492704 | PubTator, text mining | PubMed |
| miR-223: a key regulator of pulmonary inflammation. | Front Med (Lausanne) | 2023 | 37465640 | PubTator, text mining | PubMed |
| Molecular and cellular regulation of thermogenic fat. | Front Endocrinol (Lausanne) | 2023 | 37465124 | PubTator, text mining | PubMed |
| Dual intron-targeted CRISPR-Cas9-mediated disruption of the AML RUNX1-RUNX1T1 fusion gene effectively inhibits proliferation and decreases tumor volume in vitro and in vivo. | Leukemia | 2023 | 37464068 | PubTator, text mining | PubMed |
| The mutational landscape of a US Midwestern breast cancer cohort reveals subtype-specific cancer drivers and prognostic markers. | Hum Genomics | 2023 | 37454130 | PubTator, text mining | PubMed |
| Exploration of cuprotosis-related genes for predicting prognosis and immunological characteristics in acute myeloid leukaemia based on genome and transcriptome. | Aging (Albany NY) | 2023 | 37450406 | PubTator, text mining | PubMed |
| Secondary-Type Mutations in Acute Myeloid Leukemia: Updates from ELN 2022. | Cancers (Basel) | 2023 | 37444402 | PubTator, text mining | PubMed |
| The latest edition of WHO and ELN guidance and a new risk model for Chinese acute myeloid leukemia patients. | Front Med (Lausanne) | 2023 | 37435533 | PubTator, text mining | PubMed |
| Azacitidine and lenalidomide combination: a novel relapse prophylaxis regimen after allogeneic hematopoietic stem-cell transplantation in patients with acute myeloid leukemia. | Front Immunol | 2023 | 37435080 | PubTator, text mining | PubMed |
| A novel t (5; 17) (q35; q21) associated with t (8; 21) (q22; q22) in a patient with acute myeloid leukemia: case report and review of literature. | Genes Cancer | 2023 | 37427149 | PubTator, text mining | PubMed |
Cytogenetic Profiling In Paediatric Acute Leukaemia; A Report On 746 Newly Diagnosed Paediatric Cases Analyzing The Spectrum Of Recurring Chromosomal Rearrangements In B Cell Lymphoblastic And Acute Myeloid Leukaemia. | J Ayub Med Coll Abbottabad | 2023 | 37422805 | PubTator, text mining | PubMed |
| Identifying childhood leukemia with an excess of hematological malignancies in first-degree relatives in Brazil. | Front Oncol | 2023 | 37416530 | PubTator, text mining | PubMed |
| Screening for biomarkers in age-related macular degeneration. | Heliyon | 2023 | 37415944 | PubTator, text mining | PubMed |
| The epidemic of acute lymphoid leukemia in China: current trends and future prediction. | Front Oncol | 2023 | 37397360 | PubTator, text mining | PubMed |
| PHF6 maintains acute myeloid leukemia via regulating NF-κB signaling pathway. | Leukemia | 2023 | 37393343 | PubTator, text mining | PubMed |
| Ssc-mir-221-3p regulates melanin production in Xiang pigs melanocytes by targeting the TYRP1 gene. | BMC Genomics | 2023 | 37393242 | PubTator, text mining | PubMed |
A case report of complete remission of acute myeloid leukemia combined with DNMT3A, FLT3-TKD, and IDH2 gene mutations and active pulmonary tuberculosis treated with homeharringtonine + venetoclax + azacytidine. | Front Med (Lausanne) | 2023 | 37384044 | PubTator, text mining | PubMed |
| CD47 expression in acute myeloid leukemia varies according to genotype. | Haematologica | 2023 | 37381766 | PubTator, text mining | PubMed |
| Increased Bone Marrow Uptake and Accumulation of Very-Late Antigen-4 Targeted Lipid Nanoparticles. | Pharmaceutics | 2023 | 37376052 | PubTator, text mining | PubMed |
| Acute Myeloid Leukemia Expresses a Specific Group of Olfactory Receptors. | Cancers (Basel) | 2023 | 37370684 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/862/papers?page=15